US Patent Issued to Prime Merger Sub on Aug. 12 for "Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases" (Pennsylvania Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,582, issued on Aug. 12, was assigned to Prime Merger Sub LLC (Birmingham, Ala.).

"Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue inhibitors of matrix metalloproteinases" was invented by Jeffrey S. White (Chester Springs, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods for treating chronic wounds with an amniotic fluid having a therapeutically effective amount of tissue inhibitors of matrix metalloproteinases (TIMPs) are described. The amniotic fluid can be obtained from a female donor during a period of gestation when the concentration of endogenous TIMPs are at or near their maximum level. The met...